The Newswire

Your daily serving of financial goodness

Lend Lease Secures $1.6bn Joint Venture Deal in Singapore

Lend Lease Secures $1.6bn Joint Venture Deal in Singapore
Apr 02, 2015 By Simon Herrmann

In a joint venture with one of its major global investment partners, Lend Lease Group (ASX:LLC) was the highest bidder for the Paya Lebar Central site in Singapore. In an announcement to the ASX, the company said it would own 30 per cent of the large scale mixed use urban regeneration development site. The company bid $1.6bn for the Government Land Sales programme site. The site has a capacity of around 165,000sqm of development including office, retail and residential apartment use. There will also be a direct connection with the Paya Lebar Mass Rapid Transit (MRT) Interchange that connects to both the Circle and East-West lines. As per the terms of the Government Land Sales programme, the site will be on a 99-year lease agreement.

The award of this site will be subject to tender acceptance by the Urban Redevelopment Authority. The development will be funded by a combination of non-resource, project level debt and equity. “This is a great opportunity for continued success in the region, leveraging Lend Lease’s global capabilities to develop large scale urban regeneration projects in major cities around the world,” said Lend Lease CEO and Managing Director Steve McCann. “It further cements Lend Lease’s position in the Singapore market and leverages its leading integrated property capabilities encompassing development, construction, investment management and asset and property management platforms.” Overall profit for the company increased 25 per cent to $315.6m in the last half of 2014. Although there was strong growth in the Australian and UK markets, this growth was mostly offset by a decline in the US and Asia markets. LLC is up 33c, or 1.98 per cent, at $17.02 around 12:45pm on Thursday. LLC has advanced 39.54 per cent in the last 12 months.

 

Share this article

Simon Herrmann Author: Simon Herrmann Apr 02, 2015

Simon is a financial analyst at independent research firm Wise-owl who wants to change the world by disrupting the cliché approach to investment decision making with convergent thinking. Wise-owl’s goal is plain and simple: Find the best opportunities for our members by following a proven methodology and to create long-term value through high-quality advice, innovation, technology and education. We combine industry experience and the agile mentality of a start-up. Wise-owl is the future of stock market investing.

Growing Cases of Cancer Fuel Demand for Diagnostic Technology: Sienna Cancer IPO

The Australian government estimates that over 130,000 new cancer cases will be diagnosed in 2017 and the risk of individuals dying from cancer by their 85th birthday will be one in five.

Author: Simon Herrmann Jun 23, 2017

Errors

Sign Up for Free Trial
Subscribe
Recent Tweets
Recent News